Latest News about PFE
Recent news which mentions PFE
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
September 18, 2024
From Motley Fool
1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc)
September 17, 2024
From Motley Fool
Intel, Microsoft, Meta Platforms, Pfizer, Tesla: Why These 5 Stocks Are On Investors' Radars Today
September 16, 2024
From Benzinga
Is Pfizer Stock Going to $36? 1 Wall Street Analyst Thinks So.
September 16, 2024
Tickers
PFE
From Motley Fool
DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions
September 16, 2024
From Benzinga
Got $5,000? 3 Dirt Cheap Stocks to Buy Right Now
September 13, 2024
From Motley Fool
Should You Buy Novavax Stock After This Regulatory Win?
September 13, 2024
From Motley Fool
A Bull Market Is Here: 2 High-Potential Stocks Down More Than 50% to Buy Right Now
September 13, 2024
From Motley Fool
From Benzinga
GSK Halts Herpes Simplex Virus Vaccine Development, Clears Path For Other Contenders Like Moderna, BioNTech
September 11, 2024
From Benzinga
Is Hims & Hers Health the Next Teladoc?
September 11, 2024
From Motley Fool
2 Beaten-Down Stocks That Could Be Great Buys on the Dip
September 11, 2024
From Motley Fool
3 High-Yield Stocks to Buy Hand Over Fist in September
September 10, 2024
From Motley Fool
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
September 09, 2024
From Benzinga
Why Is Moderna Stock Trading Higher On Monday?
September 09, 2024
From Benzinga
Relay Therapeutics Advances Towards Pivotal Trial As It Shares Encouraging Breast Cancer Data In Heavily Pretreated Patients
September 09, 2024
From Benzinga
3 No-Brainer Dividend Stocks With Yields Above 5% You Can Buy Now and Hold at Least a Decade
September 09, 2024
From Motley Fool
3 No-Brainer Dividend Stocks to Buy in September
September 08, 2024
From Motley Fool
Bicycle Therapeutics' Lead Cancer Candidate's Has High-Opportunity, Analyst Initiates With Bullish Tone
September 06, 2024
From Benzinga
FDA Battles Backlog of Drug Factory Inspections Since COVID-19
September 06, 2024
From Benzinga
From Benzinga
A Few Years From Now, You'll Wish You Had Bought This Undervalued Stock
September 06, 2024
Tickers
PFE
From Motley Fool
From Benzinga
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
September 05, 2024
From Benzinga
Why Walgreens Boots Alliance Fell Another 22% in August
September 05, 2024
From Motley Fool
Ascendis Pharma Faces Challenges With Skytrofa And Yorvipath Pricing: Analysts Weigh In
September 04, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.